EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance

Taylor Lovsund, Fatemeh Mashayekhi, Amira Fitieh iD, James Stafford, Ismail Hassan Ismail iD

Cells · 2023

DOI: 10.3390/cells12141904 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Taylor Lovsund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology, Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, 11560 University Avenue, Edmonton,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Detailing the connection between homeostatic functions of enzymatic families and eventual progression into tumorigenesis is crucial to our understanding of anti-cancer therapies. One key enzyme group involved in this process is the Poly (ADP-ribose) polymerase (PARP) family, responsible for an expansive number of cellular functions, featuring members well established as regulators of DNA repair, genomic stability and beyond. Several PARP inhibitors (PARPi) have been approved for clinical use in a range of cancers, with many more still in trials. Unfortunately, the occurrence of resistance to PARPi therapy is growing in prevalence and requires the introduction of novel counter-resistance mechanisms to maintain efficacy. In this review, we summarize the updated understanding of the vast homeostatic functions the PARP family mediates and pin the importance of PARPi therapies as anti-cancer agents while discussing resistance mechanisms and current up-and-coming counter-strategies for countering such resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesCarcinogenesisCell Transformation, NeoplasticPoly (ADP-Ribose) Polymerase-1

Stichwörter der Autor:innen

DNA repairPARP1PARPi resistancePARylationgenome instabilityhomologous recombination

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesAntineoplastic AgentsPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1

Autor:innen und Institutionen

  • Division of Experimental Oncology, Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.
  • Department of Biophysics, Faculty of Science, Cairo University, Giza 12613, Egypt.
  • Department of Biological Sciences, Faculty of Science, University of Alberta, Edmonton, AB T6G 2E1, Canada.

ORCID-Profile: Amira Fitieh, Ismail Hassan Ismail

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council
  • Cancer Research Society

Zitieren

APA

Lovsund, T., Mashayekhi, F., Fitieh, A., Stafford, J., & Ismail, I. H. (2023). Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. Cells. https://doi.org/10.3390/cells12141904

Vancouver

Lovsund T, Mashayekhi F, Fitieh A, Stafford J, Ismail IH. Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. Cells. 2023. doi:10.3390/cells12141904

BibTeX
@article{Lovsund2023,
  author = {Lovsund, Taylor and Mashayekhi, Fatemeh and Fitieh, Amira and Stafford, James and Ismail, Ismail Hassan},
  title = {Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12141904}
}
Kostenlos starten →